Medicure Competitors

Medicure (CVE:MPH) and Covalon Technologies (CVE:COV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

Analyst Ratings

This is a breakdown of current recommendations for Medicure and Covalon Technologies, as reported by MarketBeat.

Profitability

This table compares Medicure and Covalon Technologies' net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Medicure and Covalon Technologies' top-line revenue, earnings per share and valuation.

Covalon Technologies has higher revenue and earnings than Medicure. Covalon Technologies is trading at a lower price-to-earnings ratio than Medicure, indicating that it is currently the more affordable of the two stocks.

Summary

Covalon Technologies beats Medicure on 4 of the 5 factors compared between the two stocks.

Medicure (CVE:MPH) and Emerald Health Therapeutics (CVE:EMH) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Medicure and Emerald Health Therapeutics, as reported by MarketBeat.

Profitability

This table compares Medicure and Emerald Health Therapeutics' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Medicure and Emerald Health Therapeutics' gross revenue, earnings per share and valuation.

Medicure has higher earnings, but lower revenue than Emerald Health Therapeutics. Medicure is trading at a lower price-to-earnings ratio than Emerald Health Therapeutics, indicating that it is currently the more affordable of the two stocks.

Summary

Emerald Health Therapeutics beats Medicure on 4 of the 5 factors compared between the two stocks.

IntelGenx Technologies (CVE:IGX) and Medicure (CVE:MPH) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk and valuation.

Earnings & Valuation

This table compares IntelGenx Technologies and Medicure's gross revenue, earnings per share (EPS) and valuation.

IntelGenx Technologies has higher earnings, but lower revenue than Medicure. IntelGenx Technologies is trading at a lower price-to-earnings ratio than Medicure, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares IntelGenx Technologies and Medicure's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings and target prices for IntelGenx Technologies and Medicure, as provided by MarketBeat.

Summary

IntelGenx Technologies beats Medicure on 3 of the 5 factors compared between the two stocks.

Medicure (CVE:MPH) and Quest PharmaTech (CVE:QPT) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation and dividends.

Analyst Recommendations

This is a summary of recent ratings and price targets for Medicure and Quest PharmaTech, as provided by MarketBeat.

Earnings and Valuation

This table compares Medicure and Quest PharmaTech's revenue, earnings per share (EPS) and valuation.

Quest PharmaTech has lower revenue, but higher earnings than Medicure. Medicure is trading at a lower price-to-earnings ratio than Quest PharmaTech, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Medicure and Quest PharmaTech's net margins, return on equity and return on assets.

Summary

Quest PharmaTech beats Medicure on 4 of the 5 factors compared between the two stocks.

Medicure (CVE:MPH) and Ceapro (CVE:CZO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation and dividends.

Analyst Recommendations

This is a summary of recent ratings and price targets for Medicure and Ceapro, as provided by MarketBeat.

Earnings and Valuation

This table compares Medicure and Ceapro's revenue, earnings per share (EPS) and valuation.

Ceapro has higher revenue and earnings than Medicure. Medicure is trading at a lower price-to-earnings ratio than Ceapro, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Medicure and Ceapro's net margins, return on equity and return on assets.

Summary

Ceapro beats Medicure on 5 of the 5 factors compared between the two stocks.

Medicure (CVE:MPH) and Crescita Therapeutics (TSE:CTX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.

Profitability

This table compares Medicure and Crescita Therapeutics' net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Medicure and Crescita Therapeutics, as provided by MarketBeat.com.

Valuation and Earnings

This table compares Medicure and Crescita Therapeutics' revenue, earnings per share and valuation.

Crescita Therapeutics has higher revenue and earnings than Medicure. Medicure is trading at a lower price-to-earnings ratio than Crescita Therapeutics, indicating that it is currently the more affordable of the two stocks.

Summary

Crescita Therapeutics beats Medicure on 4 of the 5 factors compared between the two stocks.